drugset / Trial / NCT02047604
(C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis
RandomizedParallel-groupTriple-blindTreatment
Summary
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Escalating Doses of SAN-300 in Patients with Active Rheumatoid Arthritis with Inadequate Response to Disease-Modifying Anti-rheumatic Drug(s).
Timeline
- Start
- 2013-12
- Primary completion
- 2017-02-23
- Completion
- 2017-03-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SAN-300 | Unknown | 0.5 mg/kg | Subcutaneous |
| Subject | SAN-300 | Unknown | 1 mg/kg | Subcutaneous |
| Subject | SAN-300 | Unknown | 2 mg/kg | Subcutaneous |
| Subject | SAN-300 | Unknown | 4 mg/kg | Subcutaneous |